Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways

The aim of the present study is to elucidate the neuronal pathways associated to NSAIDs causing a reduction of the risk and progression of Alzheimer's disease. The research was developed administering the active enantiomer of ibuprofen, dexibuprofen (DXI), in order to reduce associated gastric...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Redox Biol
Autores principales: Ettcheto, Miren, Sánchez-López, Elena, Pons, Laura, Busquets, Oriol, Olloquequi, Jordi, Beas-Zarate, Carlos, Pallas, Merce, García, Maria Luisa, Auladell, Carme, Folch, Jaume, Camins, Antoni
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5480981/
https://ncbi.nlm.nih.gov/pubmed/28646794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.redox.2017.06.003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares